SU9518 and Its Effects on Radiation Response in Cells
Author Information
Author(s): Li Minglun, Ping Gong, Plathow Christian, Trinh Thuy, Lipson Kenneth E, Hauser Kai, Krempien Robert, Debus Juergen, Abdollahi Amir, Huber Peter E
Primary Institution: German Cancer Research Centre (DKFZ), Heidelberg, Germany
Hypothesis
Does SU9518, a PDGFR inhibitor, modify the radiation response in fibroblasts and endothelial cells?
Conclusion
SU9518 reduces radiation-induced activation of fibroblasts and endothelial cells, which may help in preventing radiation-induced fibrosis.
Supporting Evidence
- SU9518 significantly inhibited PDGF-induced fibroblast and endothelial cell proliferation.
- Radiation activated PDGF signaling, which was inhibited by SU9518.
- In co-culture models, SU9518 reduced paracrine stimulation of fibroblast proliferation.
Takeaway
This study shows that a drug called SU9518 can help stop certain cells from growing too much when they are exposed to radiation, which is important for treating cancer.
Methodology
The study used western blotting, immunocytochemistry, and clonogenic assays to analyze the effects of SU9518 on cell proliferation and survival in response to radiation.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website